RE:RE:RE:RE:This sounds pretty good to meMirrorWorldMan wrote: Smokescreen to distract from AbbVie deal which is considered dead, or we would be trading higher. See it all the time with micro cap biotechs. Issue fodder of future pipeline breakthroughs to cover up past and current failures.
Maybe AbbVie bought it just for that express thought of putting it on the shelf for a considerable period of time. Keep it out of the market while they market something else.
Why not a conspiracy theory thrown in? :-))